Skip to main content

Table 1 Demographics and clinical characteristics of the study groups at enrollment.a Each group received EcoVag® capsules containing the mix of L. gasseri DSM 14869 and L. rhamnosus DSM 14870

From: Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection

Groupsa

Trial I

Trial II

BV

EcoVag®

Group-1 BV EcoVag®

Group-2 VVC EcoVag®

Group-3 VVC

No EcoVag®

n = 10

n = 9

n = 9

n = 10

Mean age (range)

35.7 (26–49)

30.0 (19–43)

33.4 (23–43)

32.5 (22–43)

Patients with history of BV/VVC (no.)

6

8

9

10

Length of symptoms (months, mean and range)

11 (0.5-30)

17.5 (1–36)

46.6 (12–120)

37.2 (12–120)

  1. n = number of women who completed the study with 6-month follow up